Synthetic hormones and the future of contraception
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying …
Post
-
-
Epiminder’s implantable EEG system for epilepsy receives FDA authorisation
Australia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous …
-
Intravascular lithotripsy: Reducing the risk of heart attacks and strokes
Heart disease remains one of the leading causes of mortality worldwide, with the World Health Organization estimating that it causes …
-
Vivasure wins CE mark for bioresorbable PerQseal Elite device
Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for …
-
Novocure’s device for metastatic NSCLC treatment gains CE Mark
Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer …
-
Biolinq raises $100m to support US launch of intradermal glucose sensor
Biolinq has secured $100m in a Series C funding round to support the regulatory approval process in the US as …
-
Trump’s microchip tariff gambit set to price hike medical devices in US
A significant increase in medical device costs will hit consumers and healthcare systems in the US if President Donald Trump …
-
FSO vs FSP: One CRO highlights key considerations for your decision
The last decade has seen a significant increase in data-focused and online technologies used in clinical trials, adding to the …
-
ARUP announces blood test to identify Alzheimer’s pathology
ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of …
-
Zimmer acquires Paragon 28 in $1.2bn deal
Zimmer Biomet has completed the previously announced acquisition of Paragon 28 for an enterprise value of approximately $1.2bn. Announced in January, …
-
BD introduces AI-based haemodynamic monitoring platform
Becton, Dickinson and Company (BD) has introduced the HemoSphere Alta platform, a haemodynamic monitoring system incorporating predictive AI-based algorithms to …
-
Biomerica’s kidney disease test gains approval for sale in UAE
The United Arab Emirates Ministry (UAE) of Health and Prevention has approved Biomerica's Fortel Kidney Disease Test for sale. This authorisation …
-
Leidos and University of Pittsburgh to expedite AI-powered disease detection
Leidos has announced a $10m investment to expedite the AI usage in disease detection and management, in a five-year partnership …
-
FDA approves Medtronic’s Simplera Sync sensor for MiniMed system
The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor with …
-
RadNet’s DeepHealth strikes $103m deal to acquire iCAD
RadNet company DeepHealth has signed a $103m deal to acquire iCAD, an AI-powered breast cancer screening company based in New …
